Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-24 @ 7:13 PM
NCT ID:
NCT04741503
Eligibility Criteria:
Inclusion Criteria:
* Latina, Black, or non-Latina White women
* Between the ages of 40-49 years
* Can write, read, and understand English
Exclusion Criteria:
-Women with greater than an average self-reported risk of breast cancer will be ineligible for participation, as evidenced by any of the following:
* Self-reported personal history of breast cancer (invasive, ductal carcinoma in situ \[DCIS\], or lobular carcinoma in situ\[LCIS\])
* Self-reported personal history of atypical hyperplasia
* Self-reported first degree family member with history of breast cancer (e.g., mother, sister)
* Self-reported known underlying genetic mutation such as a BRCA1/BRCA2 gene
* Self-reported prior thoracic or chest wall radiation therapy
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
40 Years
Maximum Age:
49 Years
Study:
NCT04741503
Study Brief:
Protocol Section:
NCT04741503